Publications

Franklin M, Emden MR, Bauer E, Nguyen AT, Sacks N, Kawamatsu S, Kawano Y,  Mitrani-Gold FS, Joshi AV, Ju S, Preib MT. Prevalence of acute uncomplicated cystitis in Japan. Poster presentation, IDWeek, October 2023.

Franklin M, Emden MR, Kautz S, Nguyen AT, Sacks NC, Ju S, Mitrani-Gold FS, Joshi AV, Preib MT. Cost burden of patients with oral antibiotic treatment failure for uncomplicated urinary tract infection in the United States. Poster presentation, IDWeek, October 2023.

Moyer HL, Kim S, Lam BP, Valdiviezo A, Richardson L, Menon R, Rusyn I, Han A. Evaluating mechanistic underpinnings of environmental chemical effects on feto-maternal interface using a human organ-on-chip model. Texas A&M University Superfund External Advisory Board Meeting, College Station, TX, October 2023.

Nelson CB, Jiang X, Suh M, Fryzek J. Prevention of respiratory syncytial virus hospitalizations (RSVH) in US infants who paid through Medicaid would have a greater benefit for Black, Hispanic, Asian/Pacific Islander, Native American and Other race/ethnicity infants, and have a substantial impact on overall RSVH burden and related costs: Rates of respiratory syncytial virus hospitalization (RSVH) among US infants by race/ethnicity and insurance payer, NIS 2018-2020. Poster 1536169, IDWeek 2023, Boston, MA, October 2023.

Blatt A, Suh M, Walter E, Jr., Wood CT, Espinosa C, Enriquez-Bruce ME…Movva N, Reichert H, Fryzek JP, et al. Seasonality of infant respiratory syncytial virus associated bronchiolitis around the US since the onset of COVID-19: Results from four US health systems 2016-17 through 2022-23. Poster 1535431, IDWeek 2023, Boston, MA, October 2023.

Wharton GT, Becker C, Bennett D, Burcu M, Bushnell G, Ferrajolo C, Kaplan S, McMahon AW, Movva N, Raman SR, Scholle O, Suh M, Sun JW, Horton DB. Overview of global real-world data sources for pediatric pharmacoepidemiologic research. Poster presentation at the 39^th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Halifax, Nova Scotia, August 2023 [ISPE Journal].

Covington TR, Sterner TR. Physiologically-based pharmacokinetic model to predict HFC-134a in exhaled breath following albuterol inhaler use. Poster presented at the 2023 Toxicology and Risk Assessment Conference, Miamisburg, OH, August 25, 2023.

Moyer HL, Kim S, Lam BP, Valdiviezo A, Richardson L, Menon R, Rusyn I, Han A. Evaluating mechanistic underpinnings of environmental chemical effects on feto-maternal interface using a human organ-on-chip model. Texas A&M University Toxicology Annual Retreat, College Station, TX, August 2023.

Mitchell ME, Bylsma LC, Shara NM, Fernandez SJ, Catlett JP, Lai JS, Dong K, Fryzek JP, Daver N, Allen C, Broome CM.  Novel methods for the identification of a rare disease, hemophagocytic lymphohistiocytosis (HLH). Poster presented at the International Society for Pharmacoepidemiology annual meeting, Poster 166, Halifax, Nova Scotia, August 2023.

Bonkowsky J, Healey B, Sacks NC, McLin R, Cyr PL, Sawyer EK, Stephen CD, Eichler F. Point of care analysis for men with adrenomyeloneuropathy: A retrospective study of real world data. Poster presentation, European Academy of Neurology, Budapest, Hungary, July 2023.

Lockwood CM, Price C. My paper was not accepted, what did I do wrong? Submitting wisely for publication. Winter Program of the University of São Paulo, Brazil School of Nursing; https://www.youtube.com/live/GIJM422jY_M?feature=share&t=3052, July 2023.

Bonkowsky J, Healey B, Sacks NC, McLin R, Cyr P, Sawyer E, Stephen CD, Eichler F. Healthcare utilization, burden of illness, and mortality in adults with adrenomyeloneuropathy: The case for genetic therapies. Poster presentation, American Society of Cell and Gene Therapy Meeting, Los Angeles, CA, May 2023.

Seo S, Healey B,  McLin R, Sacks N,  Benson C, Citrome L. Health disparities among patients with schizophrenia in an integrated healthcare system. Poster presentation, Psych Congress Elevate 2023, May 30-June 2, 2023.

Jensen I, Srivastava K, Minshall M, Kemp R. Estimating the lifetime burden of illness in patients with bronchiolitis obliterans syndrome. Abstract EE539, ISPOR 2023.

Fender CL, Morshead M, Cohen C, Truong L, Rohlman D, Tanguay R, Jaramillo-Garcia M. Water contaminants in the Portland Harbor: Addressing community concerns related to chemicals and toxicity. Seminar presentation at Environmental and Molecular Toxicology Seminar Series, Corvallis, OR, 2023.

Fender CL, Morshead M, Cohen C, Truong L, Rohlman D, Tanguay R, Jaramillo-Garcia M. Using suspect and nontarget LC-HRMS and high throughput toxicity assays to identify and prioritize surface water contaminants. Oral presentation at Pacific Northwest (PNW) SETAC Annual Conference, Troutdale, OR, 2023.

Fender CL, Morshead M, Cohen C, Truong L, Rohlman D, Tanguay R, Jaramillo-Garcia M. Using suspect and nontarget LC-HRMS and high throughput toxicity assays to identify and prioritize surface water contaminants. Poster presentation at PANWAT Annual Conference, Portland, OR, 2023.

Fender CL, Morshead M, Cohen C, Truong L, Rohlman D, Tanguay R, Jaramillo-Garcia M. Suspects and nontarget chemical analyses to address community concerns related to chemicals and toxicity in the Portland harbor. Poster presentation at SRP Annual Conference, Albuquerque, NM, 2023.

Bean K, Miller B, Jensen I, Fields C, Pang F. Evaluating the face validity of health state utility values (HSUVS) for metachromatic leukodystrophy (MLD). Abstract EE285, ISPOR 2023.

Bean K, Olaye A, Miller B, Jensen I, Dean R, Pang F. Direct cost analysis associated with the management of patients with metachromatic leukodystrophy (MLD) across nine European countries. Abstract EE408, ISPOR 2023.